Publications by authors named "Christopher Joynes"

Claim this Profile
I
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non small cell lung cancers.
Jacqueline F Doody, Ying Wang, Sheetal N Patel, Christopher Joynes, Sui Ping Lee

Mol Cancer Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
Philipp Steiner, Christopher Joynes, Rajiv Bassi, Su Wang, James R Tonra

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Nick Loizos, Yan Xu, Jim Huber, Meilin Liu, Dan Lu, Christopher J Joynes

Mol Cancer Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.
Hiromasa Tsuiki, Mehdi Tnani, Isamu Okamoto, Lawrence C Kenyon, David R Emlet, Christopher J Joynes

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors.
Isamu Okamoto, Hiromasa Tsuiki, Lawrence C Kenyon, Andrew K Godwin, David R Emlet, Christopher J Joynes

Am J Pathol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis